XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Share-based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Restricted Stock Units Activity

The following table provides a summary of restricted stock units activity during the six months ended June 30, 2024:

 

 

Number of
Shares

 

 

Weighted Average
Grant Date Fair Value
Per Share

 

Unvested restricted stock units at December 31, 2023

 

 

1,031,545

 

 

$

18.27

 

Granted

 

 

1,430,880

 

 

$

14.45

 

Vested

 

 

(369,359

)

 

$

16.63

 

Forfeiture

 

 

(176,478

)

 

$

16.41

 

Unvested restricted stock units at June 30, 2024

 

 

1,916,588

 

 

$

15.90

 

Summary of Share/Stock-based Compensation Expense Recorded in The Accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss

Share-based compensation expense recorded in the accompanying condensed statements of operations is as follows (in thousands):

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development expense

 

$

4,709

 

 

$

3,410

 

 

$

9,362

 

 

$

6,790

 

Selling, general and administrative expense

 

 

8,321

 

 

 

6,067

 

 

 

16,312

 

 

 

12,134

 

Total share-based compensation expense

 

$

13,030

 

 

$

9,477

 

 

$

25,674

 

 

$

18,924

 

Summary of The Unvested Common Stock

The following table provides a summary of the unvested common stock awards activity during the six months ended June 30, 2024.

 

 

Number of
Shares

 

 

Weighted Average
Grant Date Fair Value
Per Share

 

Unvested common stock as of December 31, 2023

 

 

747,679

 

 

$

16.00

 

Vested

 

 

(376,591

)

 

$

16.00

 

Forfeiture

 

 

(25,415

)

 

$

16.00

 

Unvested common stock as of June 30, 2024

 

 

345,673

 

 

$

16.00

 

Schedule of fair value of our common stock to be issued under the ESPP

The fair value of our common stock to be issued under the ESPP is estimated at the date of grant using a Black-Scholes option-pricing model with the following assumptions:

 

 

Six Months Ended
June 30,

 

 

2024

 

2023

Expected term (in years)

 

0.5

 

0.5

Expected volatility

 

63.45%

 

63.57%

Risk-free interest rate

 

5.40%

 

5.24%

Expected dividend yield

 

 

 

Summary of The Black-Scholes Option Pricing Model to Estimate The Fair Value of Stock Option Granted

The Company used the Black-Scholes option pricing model to estimate the fair value of stock option awards granted with the following assumptions:

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

2024

 

2023

 

2024

 

2023

Expected term (in years)

 

5.3 - 6.1

 

5.3 - 6.2

 

5.3 - 6.7

 

5.3 - 6.3

Expected volatility

 

68.57% - 69.18%

 

69.21% - 81.65%

 

68.27% - 70.57%

 

69.21% - 81.98%

Risk-free interest rate

 

4.24% - 4.47%

 

3.47% - 3.98%

 

3.90% - 4.47%

 

3.47% - 4.08%

Expected dividend yield

 

 

 

 

2021 Equity Incentive Plan  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity

The following table provides a summary of stock option activity during the six months ended June 30, 2024.

 

 

Options

 

 

Weighted-Average
Exercise Price
Per Share

 

 

Weighted-Average
Remaining
Contractual Term

 

 

Aggregate
Intrinsic Value
(in thousands)

 

Outstanding at December 31, 2023

 

 

10,211,758

 

 

$

17.10

 

 

 

 

 

 

 

Granted

 

 

2,597,862

 

 

$

14.36

 

 

 

 

 

 

 

Exercised

 

 

(27,013

)

 

$

13.76

 

 

 

 

 

$

68

 

Forfeiture

 

 

(578,985

)

 

$

16.89

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

12,203,622

 

 

$

16.54

 

 

 

7.9

 

 

$

2,237

 

Vested and expected to vest at June 30, 2024

 

 

12,203,622

 

 

$

16.54

 

 

 

7.9

 

 

$

2,237

 

Exercisable at June 30, 2024

 

 

6,400,855

 

 

$

16.68

 

 

 

7.3

 

 

$

1,011